ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Former NCAB chairman, President’s Cancer Panel member Paul Calabresi dead at 73.

October 31, 2003

Seattle Cancer Care Alliance Outpatient Clinic to Open – Jan. 19, 2001

June 7, 2021

“Triple-Negative” Should Be Split Into Subtypes, Say Researchers

February 22, 2013

Adamson Is Named Acting Deputy; Broder Begins Search For Roper Replacement

May 25, 1990

Centers Network Release “Version 1.0” Of Clinical Guidelines for Eight Cancers

March 15, 1996

Workshop Calls For Improved Surgical Oncology Training Programs

December 2, 1983